We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urged to Provide Guidance on Subpopulation ‘Action Plan’
FDA Urged to Provide Guidance on Subpopulation ‘Action Plan’
Drugmakers are urging the FDA to publish extensive guidance on even the most basic issues related to clinical trial diversity as the agency steps up its efforts to increase diversity in clinical trial subject populations.